Guillain-Barré syndrome is the most common cause of acute flaccid paralysis worldwide.
Most patients present with an antecedent illness, most commonly upper respiratory tract …

Immune checkpoint inhibitor (ICI) therapy has revolutionized the management of various
cancers with previously poor prognosis. Despite its great efficacy, the therapy is associated …

The present review summarizes up-to-date evidence addressing the frequently discussed
clinical controversies regarding the use of immune checkpoint inhibitors (ICIs) in cancer …

Abstract Purpose of Review The use of immune checkpoint inhibitors (ICIs) for oncologic
indications is associated with immune-related adverse events (irAEs). Patients with pre …

Immune checkpoint inhibitors (ICIs) have been increasingly used in the treatment of various
types of tumors with favorable results. But these treatments also led to a variety of immune …

Objective To evaluate prevalence and clinical features of immune-related adverse events
(irAEs) to immune checkpoint inhibitors (ICIs) in accordance with the gender of treated …

Objective The purpose of the present study is to report the clinical characteristics of
polyradiculoneuropathy induced by immune checkpoint inhibitors (ICIs). Methods We …

Immune checkpoint inhibitors (ICIs) have been approved for the treatment of various
malignancies with promising clinical outcomes. Treatment can, however, be accompanied …

The potential increased risk of immune-related adverse events (irAEs) post-influenza
vaccine is a concern in patients receiving immune checkpoint inhibitors (ICI). We conducted …

Objective The purpose of this study is to report the clinical characteristics of dysautonomia
associated with immune checkpoint inhibitors (ICIs). Methods We reported two patients with …